Campylobacter rectus Infection Leads to Lung Abscess: A Case Report and Literature Review

Abstract

Background

Campylobacter rectus is one of the anaerobic bacteria in the mouth.

Case Presentation

We report the case of a 73-year-old man admitted for lung abscess caused by Campylobacter rectus with unique manifestations under electronic bronchoscopy, and the pathogen is first reported to be confirmed by metagenomic next-generation sequencing (mNGS) through testing bronchoalveolar lavage fluid.

Conclusion

Sometimes, Campylobacter rectus can cause infection outside the mouth such as lung abscess. Most patients have good outcomes.

Video abstract

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:

https://youtu.be/ZCyY2vJ3XRw

Keywords:

• Campylobacter rectus
• Wolinella recta
• lung abscess
• metagenomic next-generation sequencing
• mNGS
• electronic bronchoscopy

Background

Campylobacter rectus is one of the anaerobic bacteria in the mouth, which was previously known as Wolinella recta.¹ It was identified as a common pathogen closely related to human periodontal disease in 1979.² In 1984, the first case of Campylobacter rectus infection outside the oral was reported.³ Then, it was reassigned to the genus Campylobacter in 1991.⁴

Case Report

A 73-year-old man with a history of chronic obstructive pulmonary disease (COPD) for more than 10 years, he regularly inhaled salmeterol/fluticasone propionate (50µg/500µg) twice a day. He had 30 pack-years of smoking history and quit smoking for more than 10 years. He was a farmer by profession. He was admitted to hospital with cough and hemoptysis for more than five months.

Admission blood tests showed a white cell count of 5.8 × 10⁹/L, C-reactive protein 3.1 mg/L and interleukin-6 16.32pg/mL. All of sputum smear acid-fast staining, tuberculin test and tuberculosis antibody test were negative. Serum biomarkers of lung cancer, such as carcinoembryonic antigen (CEA), Cytokeratin-19-fragment (CYFRA21-1), squamous cell carcinoma antigen (SCC), and neuron-specific enolase (NSE) were negative.

The images of computed tomography (CT) scan of the chest revealed large dense shadows and cavity formation in the inferior lobe of the left lung (Figure 1A). The electronic bronchoscopy showed a big and white neoplasm in the lower left lung, with a narrow opening and a lot of white necrotic material in the subsegment (Figure 2). Biopsy revealed chronic inflammation of endobronchial membrane with lymphoid follicular hyperplasia, but without any definite tumor cells (Figure 3). Acid-fast staining and Periodic Acid-Schiff (PAS) staining were both negative. Not only the traditional culture (including aerobic and anaerobic) but also the galactomannan (GM) test of bronchoalveolar lavage fluid were negative. Surprisingly, the mNGS of bronchoalveolar lavage fluid revealed 4415 sequences of Campylobacter rectus and 1091 sequences of Parvimonas micra.

Figure 1 (A) CT revealed large dense shadows and cavity formation in the inferior lobe of the left lung. (B) The results of CT re-examination suggested that, the area of infection in the inferior lobe of the left lung was significantly reduced and the cavity was smaller. (C) The condition of the lung was further improved than before.

Figure 2 (A) The opening of the left lower lobe is narrow. (B and C) There is a big and white neoplasm in the lower left lung, with a lot of white necrotic material in the subsegment.

Figure 3 Biopsy revealed chronic inflammation of bronchial mucosa with lymphoid follicular hyperplasia, but no definite tumor cells (400X).

Empirical antimicrobial therapy commenced immediately with intravenous tazobactam/piperacillin (4.5g three times daily) and ornidazole (500 mg twice daily) from the first day in the hospital. One week later when we got the result of mNGS, etimicin (300mg one time daily) was used in combination to enhance treatment against Gram-negative bacteria. Another two weeks later, the symptom of diarrhea in the patient was considered to be due to the imbalance of intestinal flora induced by long-term extensive use of broad-spectrum antibiotics. Therefore, the anti-infective treatment regimen was reduced to etimicin only. The patient was hospitalized for one month. The results of CT re-examination suggested that the area of infection in the inferior lobe of the left lung was significantly reduced, and the cavity was smaller (Figure 1B). After he was discharged from hospital, he was treated with oral levofloxacin (0.5g once daily) for four months. The condition of the lung was further improved than before (Figure 1C).

Discussion

Campylobacter rectus is Gram-negative, with no spores and can be cultured in microaerobic or anaerobic state. Its colonies are translucent, rough, flat and non-hemolytic. The morphology of Campylobacter rectus is straight rod-shaped, arcuate or S shape. Urease and oxidase tests are both negative.

Campylobacter rectus is one of the oral colonization flora. In 2007, a large study involving 1294 healthy adults in southern Finland found that 31.3% of them had been detected Campylobacter rectus in the saliva.² Sometimes it can cause infections outside the mouth, but the reasons are not completely clear. The table summarizes the data of 20 cases (including this case) searched from the literatures (Table 1). The age of the patients ranged from 10 months to 75-year-old. Most of the patients ranged from 50 to 70 years old (12/20), among which 55% patients (11/20) had dental caries, periodontitis, poor oral hygiene and other oral risk factors, and 15% (3/20) had a history of malignant tumor. The site of infection is varied, including empyema, brain abscess, osteomyelitis, etc. In terms of prognosis, only two patients died unfortunately, while the remaining patients (18/20) were discharged after effective anti-infection treatment, puncture or incisional drainage, and the success rate of the comprehensive treatment was 90%. Pathogens can be identified in a variety of ways, including traditional culture, 16S rRNA gene sequencing, matrix-assisted laser desorption/hours-of-flight mass spectrometry, and mNGS. The duration of anti-infective therapy for Campylobacter rectus varied from 23 days to 6 months, except for 2 deaths.

Table 1 Summary of the Characteristics Among Reported Invasive Campylobacter rectus Infections in 20 Cases (Including This Case)

Case	Reported Year	Sex	Age	Risk Factors	Course of Disease	Diagnosis	Identification Technology	Antibiotic MIC (mg/L)	Course of Antibiotic Treatment	Surgical and Antibiotic Treatment	Outcome	References
1	1984	M	62Y/O.	Poor oral hygiene, periodontitis, alcoholism	4 months	Chest wall abscess	Tissue culture	Metronidazole=1; penicillin G=0.25; clindamycin=0.25; tetracycline≤0.25; colistin=1; rifampin=0.5; vancomycin>128	6 months	Penicillin, drainage	Recovery	[^Citation3]
2	1990	F	62Y/O.	None	1 week	Brain abscess	Pus culture	Not assessed	2 months	Aspiration, penicillin, chloramphenicol, clindamycin	Recovery	[^Citation8]
3	1994	M	37Y/O.	Dental abscesses and gum bleeding, periodontal disease, urethritis	1 week	Sacroiliitis and septicemia	Blood culture	Clindamycin≤0.5; Penicillin=0.06; metronidazole≤0.5; cefoxitin≤0.5; piperacillin≤2; imipenem=0.125	4 months	Puncture of the joint, cloxacillin, ampicillin, gentamicin, imipenem, penicillin, clindamycin	Recovery	[^Citation9]
4	2005	F	32Y/O.	Large-cell lymphoma, anticancer chemotherapy	1 day	Breast cellulitis with neutropenia	Secretion culture; 16S rRNA gene sequencing	Not assessed	4 weeks	Drainage, vancomycin, clindamycin, aztreonam	Recovery	[^Citation10]
5	2008	M	24Y/O.	Meningoradiculitis	2 weeks	Vertebral abscess	Pus culture; 16S rRNA gene sequencing	Clindamycin=0.094	6 weeks	Hemilaminectomy, ceftriaxon, aciclovir	Recovery	[^Citation11]
6	2008	M	54Y/O.	Diabetes mellitus, hypertension, and hyperlipidemia	2 days	Subdural abscess	Subdural aspirate culture; 16s rRNA gene sequencing	Penicillin G=0.064; metronidazole=0.125; clindamycin=0.125	4 months	Craniotomy, drainage, endoscopic sinus surgery, vancomycin, ceftazidime, ceftriaxone, metronidazole, penicillin G	Recovery	[^Citation12]
7	2009	M	66Y/O.	Gastroesophageal adenocarcinoma, chemoradiation, poor oral hygiene	6 months	Hard palate soft tissue abscess	16S rRNA gene sequencing	Not assessed	Not reported	Puncture, amoxicillin/clavulanate	Recovery	[^Citation1]
8	2011	M	64Y/O.	Poor oral hygiene, gingivitis, dental caries	2 weeks	Right lower extremity osteomyelitis	Necrotic tissue culture; 16S rRNA gene sequencing	Not assessed	3 months	Amputation, amoxicillin-clavulanate, ciprofloxacin	Recovery	[^Citation13]
9	2011	M	56Y/O.	Poor oral hygiene, gingivitis, dental caries	4 weeks	Empyema thoracis	Pus culture; 16S rRNA gene sequencing	Amoxycillin/clavulanate=0.064	2 months	Drainage, amoxycillin/clavulanate	Recovery	[^Citation13]
10	2011	F	41Y/O.	None	2 weeks	Subdural empyema and ruptured mycotic intracranial aneurysm	Blood culture; Pus culture; 16S rRNA gene sequencing	Not assessed	–	Decompressive craniotomy, vancomycin, ceftriaxone, metronidazole	Death	[^Citation13]
11	2014	M	55Y/O.	Tooth extraction for dental caries	8 days	Cavernous sinus thrombosis	Blood culture (+); 16S rRNA gene sequencing	Not assessed	–	Vancomycin, clindamycin, piperacillin/tazobactam	Recovery	[^Citation14]
12	2016	M	15Y/O.	Keep cats and dogs	13 days	Otitis media	16S rRNA gene sequencing	Not assessed	25 days	Cefditoren-pivoxil, prulifloxacin, ceftriaxone, ampicillin, amoxicillin	Recovery	[^Citation15]
13	2016	F	10 months	None	5 days	Empyema thoracis	Pleural fluid culture	Not assessed	6 weeks	Drainage, vancomycin, Ceftriaxone, Piperacillin-tazobactam, ampicillin-sulbactam, amoxicillin-clavulanate	Recovery	[^Citation16]
14	2016	M	75Y/O.	Diabete, impaired renal function, periodontitis	1 week	Empyema thoracis	16S rRNA gene sequencing	Not assessed	2months	Drainage, sulbactam-ampicillin, garenoxacin, levofloxacin	Recovery	[^Citation17]
15	2017	M	66Y/O.	Tooth abscess	8 weeks	Brain abscesses	MALDI-TOF MS	Metroperan=0.012	7 months	Drainage, Meropenem, doxycycline	Recovery	[^Citation18]
16	2017	M	69Y/O.	Alcoholism, renal failure, atherosclerosis, COPD, poor dental hygiene	1 week	Septic shock, necrotic pneumoniae, thoracic empyema	Pleural liquid culture; MALDI-TOF MS	Metronidazole=0.094; clinomycin=0.016; metroperan<0.002; amoxycillin/clavulanate=0.047	–	Drainage, Amikacin, amoxicillin-clavulanate	Death	[^Citation19]
17	2018	F	70Y/O.	Tooth extraction	Not reported	Osteomyelitis, cavernous sinus thrombosis, septic pulmonary embolism	Blood culture	–	27 days	Ampicillin/sulbactam, fluconazole, meropenem, metronidazole	Recovery	[^Citation20]
18	2019	M	65Y/O.	Cerebrovascular disease, alcoholism, poor dental hygiene	Not reported	Lung consolidation with thoracic empyema	16S rRNA gene sequencing; MALDI-TOF MS	–	4 weeks	Drainage, tazobactam/piperacillin, clarithromycin, meropenem, amoxicillin/clavulanate	Recovery	[^Citation21]
19	2019	M	64Y/O.	Radiotherapy and chemotherapy for nasopharyngeal carcinoma, otitis media	5 months	Meningitis	mNGS; 16S rRNA gene sequencing	–	1 month	Drainage, cefodizime, levofloxacin, moxifloxacin, cefufoxime, metronidazole	Recovery	[^Citation22]
20	2020	M	73Y/O.	COPD, poor oral hygiene	1 month	Lung abscess	mNGS	–	3 months	Piperacillin-tazobactam, Ornidazole, Etimicin, levofloxacin	Recovery	Present case

Abbreviations: MALDI-TOF MS, Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; COPD, chronic obstructive pulmonary disease; mNGS, metagenomic next-generation sequencing.

Electronic bronchoscopy, as a routine technique for respiratory infections, plays an important role in the diagnosis and treatment of respiratory diseases. This technique can detect early abnormalities in the lumen that might not be found by CT scanning. At the same time, samples can be taken for corresponding tests. In this case, a large amount of white necrotic material was found in the bronchial lumen at the lesion site, blocking the lumen and attaching to the wall. This is the first reported case of lung abscess caused by Campylobacter rectus under the electronic bronchoscope.

There are few literatures on the anti-infection treatment of Campylobacter rectus. In 2002, a study in Italian about periodontal anaerobe which can cause systemic infection found that Campylobacter rectus is sensitive to a variety of antibiotics except moxifloxacin,⁵ such as penicillin, amoxycillin/clavulanate, cefoxitin, etc. In 2007, another study in Italian about anti-microbial susceptibility of oral micro-organisms also confirmed that Campylobacter rectus was sensitive to multiple antibiotics, and none of the seven groups of samples produced β-lactamase.⁶ As a study on the antimicrobial resistance of this bacterium in 2020, Rams et al from the Netherlands studied the in vitro resistance of periodontal pathogens to four antibiotics, and found no resistance to Campylobacter rectus.⁷

Conclusion

Campylobacter rectus is an oral colonizing bacterium which can cause infection outside the mouth. Most patients have a good outcome. In this case, a characteristic pattern of white necrotic material forms in the bronchial lumen. Metagenomic next-generation sequencing is one of the rapid diagnostic methods.

Data Sharing Statement

All raw data in the manuscript has been uploaded to the submission system.

Ethics Approval and Consent to Participate

The study has been approved by the Independent Ethics Committee of Nanjing Tongren Hospital (Approval No: TRLLKY2020013.1). We obtained the patient’s consent and signed the informed consent.

Consent for Publication

The manuscript is approved by all authors for publication.

Patient Consent

The patient provided written informed consent for the case details and accompanying images to be published.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

No conflict of interest exists in the submission of this manuscript, and it is approved by all authors for publication.